Current and Future Directions in the Prevention and Treatment of HPV-Related Diseases

Dear Colleagues,

Human papillomavirus (HPV) infection represents one of the major causes of infection-related cancer both in women and men. HPV infection is known as a first cause in cervical cancer, and numerous studies have extended the role of infection to anogenital and oropharyngeal cancers, involving over 63,000 cases, worldwide. The high burden of HPV-related diseases highlights the need to implement preventive and diagnostic measures. Primary and secondary prevention strategies, such as HPV vaccination and screening, have been introduced in recent decades, leading to important reductions in cervical cancer cases and mortality. However, effective measures are scant for other HPV-related diseases. In addition, scientific evidence underscores the need for new biomarkers useful as predictors in the progression of cervical and non-cervical lesions.

On this basis, we are pleased to invite you to submit your research work and reviews that will be supportive in the development of new methodologies for diagnosis and prevention of HPV-associated diseases. Meta-analysis and systematic reviews of existing effective preventive tools, along with clinical trials and observational studies, are welcome. We will appreciate any contributions that address relevant issues in the field of prevention, early detection, screening, and treatment of HPV infections.

We look forward to receiving your contributions.

Prof. Dr. Andrea Piana
Dr. Narcisa Muresu
Dr. Mariangela Valentina Puci
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• human papillomavirus (HPV)
• HPV-screening
• HPV vaccination
• methylation
• self-sampling collection
• cervical cancer